# 바이오스페이스 일일 뉴스 리포트 - 2026년 02월 10일


## 주요 헤드라인

1. **Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/eli-lilly-enters-car-t-realm-with-2-4b-orna-buy-starting-with-autoimmune>

2. **Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/eli-lilly-enters-car-t-realm-with-2-4b-orna-buy-starting-with-autoimmune>

3. **Biogen’s Much Anticipated Tau Readout in Alzheimer’s Will Spur More Questions (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/biogens-much-anticipated-tau-readout-in-alzheimers-will-spur-more-questions>

4. **Biogen’s Much Anticipated Tau Readout in Alzheimer’s Will Spur More Questions (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/biogens-much-anticipated-tau-readout-in-alzheimers-will-spur-more-questions>

5. **Novo Sues Hims & Hers Over Compounded Version of Oral Wegovy Pill (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novo-sues-hims-over-compounded-version-of-oral-wegovy-pill>

6. **Liver Toxicities Force Pause on Two Dose Groups of UniQure’s Mid-Stage Fabry Study (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/liver-toxicities-force-pause-on-2-dose-groups-of-uniqures-mid-stage-fabry-study>

7. **Ultragenyx’s Gene Therapy Shows Long-Term Efficacy in Two Sanfilippo Studies (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/ultragenyxs-gene-therapy-shows-long-term-efficacy-in-two-sanfilippo-studies>


---
*2026년 02월 10일 바이오스페이스 뉴스 피드에서 생성된 리포트*